Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2457867 | Small Ruminant Research | 2008 | 4 Pages |
Forty-eight Pelibuey × Katahdin (38.8 ± 0.67 kg) crossbred male lambs were used in a 32-day feeding trial (four pens per treatment in a randomized complete block design), to evaluate the influence of zilpaterol (β2-agonist) supplementation level on growth performance and carcass characteristics. Lambs were fed a dry-rolled corn-based finishing diet (3.04 Mcal/kg of ME) supplemented with 0, 0.15, 0.20, or 0.25 mg/kg of live weight d−1 zilpaterol (as zilpaterol chlorhydrate, Zilmax®, Intervet México, México City). DM intake averaged 1.099 ± 0.042 kg/d and was not affected (P = 0.40) by treatments. Compared with control lambs, zilpaterol supplementation increased gain efficiency (15.8%, P < 0.03), apparent energy retention per unit DMI (10.9%, P = 0.03), and tended to increased daily gain (16%, P < 0.07) and total gain (17.7%, P < 0.08). Zilpaterol supplementation did not affect (P = 0.20) carcass weight, longissimus muscle area (LM), or fat thickness, but increased (2.3%, P = 0.04) carcass dressing percentage and reduced (36%, P < 0.01) kidney-pelvic fat. Increasing level of zilpaterol supplementation increased total weight gain (linear component, P < 0.05), gain:feed (linear component, P < 0.01), and dressing percentage (linear component, P < 0.02), and decreased (linear component, P < 0.01) kidney-pelvic fat. We conclude that zilpaterol supplementation enhances growth performance and dressing percentage in lambs in a manner comparable to that of cattle (greater muscle accretion, reduced body fat). Responses to zilpaterol was optimal when supplemented at 0.20 mg of zilpaterol/kg of live weight d−1.